Literature DB >> 8228250

Increased synthesis and secretion of a 14-kDa phospholipase A2 by guinea pig alveolar macrophages. Dissociation from arachidonic acid liberation and modulation by dexamethasone.

R Hidi1, B B Vargaftig, L Touqui.   

Abstract

The occurrence of a 14-kDa secretory phospholipase A2 (PLA2) in guinea pig alveolar macrophages (AM) and its relationship with the release of arachidonic acid (AA) were investigated. Freshly collected AM showed no detectable PLA2 activity as measured by the in vitro hydrolysis of phosphatidic acid. However, the PLA2 activity increased progressively when AM were maintained in culture to reach a level 60- to 100-fold greater than basal values within 20 h, with a parallel secretion into the incubation medium. By contrast, the activities of other phospholipid-hydrolyzing enzymes (platelet-activating factor acetylhydrolase and lysophospholipase) were modified only marginally. Both intra- and extracellular increases of PLA2 activity were abrogated with actinomycin D or cycloheximide. The enhanced PLA2 activity preferentially hydrolyzed negatively charged phospholipids in the order phosphatidic acid > phosphatidylglycerol > phosphatidylethanolamine > phosphatidylcholine, had an optimum pH of 7.5, and required a millimolar Ca2+ concentration for optimal activity and an apparent molecular mass of 14 kDa. Taken together, these results suggest that cultured AM elaborate an enzyme similar to the group II PLA2. On the other hand, our results show that AM hydrolyzed exogenous 2-arachidonoyl phosphatidylcholine and released AA and metabolites on FMLP stimulation. However, in contrast to the increase observed in the activity of the 14-kDa PLA2, the enzymatic activity involved in the hydrolysis of 2-arachidonoyl phosphatidylcholine and AA release remained constant with the culture duration of AM. Finally, dexamethasone markedly inhibited the increase of PLA2 activity, but only marginally inhibited the release of AA and metabolites from FMLP-stimulated AM. We conclude that guinea pig AM elaborate a 14-kDa PLA2 similar to the group II PLA2 through RNA- and protein synthesis-dependent processes. This elaboration appears to be induced by the adhesion of AM and is clearly dissociated from the liberation of AA.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8228250

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  High specificity of human secretory class II phospholipase A2 for phosphatidic acid.

Authors:  Y Snitko; E T Yoon; W Cho
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

2.  Down-regulation by prostaglandins of type-II phospholipase A2 expression in guinea-pig alveolar macrophages: a possible involvement of cAMP.

Authors:  D Vial; L Arbibe; N Havet; C Dumarey; B Vargaftig; L Touqui
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

3.  Posttranscriptional effect of insulin-like growth factor-I on interleukin-1beta-induced type II-secreted phospholipase A2 gene expression in rabbit articular chondrocytes.

Authors:  C Jacques; G Béréziat; L Humbert; J L Olivier; M T Corvol; J Masliah; F Berenbaum
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

4.  Mechanisms of prostanoid synthesis in human synovial cells: cytokine-peptide synergism.

Authors:  J M Bathon; F H Chilton; W C Hubbard; M C Towns; N J Solan; D Proud
Journal:  Inflammation       Date:  1996-10       Impact factor: 4.092

5.  Differential involvement of protein kinase C in activating cytosolic phospholipase A2 in alveolar macrophages and monocyte differentiated U937 cells.

Authors:  M T Withnall; A M Pennington; M Hagen
Journal:  Inflamm Res       Date:  1995-08       Impact factor: 4.575

Review 6.  Role of secretory phospholipase a(2) in CNS inflammation: implications in traumatic spinal cord injury.

Authors:  W Lee Titsworth; Nai-Kui Liu; Xiao-Ming Xu
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-06       Impact factor: 4.388

7.  Secreted phospholipase A2 is increased in meconium-stained amniotic fluid of term gestations: potential implications for the genesis of meconium aspiration syndrome.

Authors:  Roberto Romero; Bo Hyun Yoon; Piya Chaemsaithong; Josef Cortez; Chan-Wook Park; Rogelio Gonzalez; Ernesto Behnke; Sonia S Hassan; Francesca Gotsch; Lami Yeo; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2014-01-06

8.  Therapy with interleukin-2 induces the systemic release of phospholipase-A2.

Authors:  G J Wolbink; C Schalkwijk; J W Baars; J Wagstaff; H van den Bosch; C E Hack
Journal:  Cancer Immunol Immunother       Date:  1995-11       Impact factor: 6.968

Review 9.  The secretory phospholipase A2 group IIA: a missing link between inflammation, activated renin-angiotensin system, and atherogenesis?

Authors:  Dimitar Divchev; Bernhard Schieffer
Journal:  Vasc Health Risk Manag       Date:  2008

10.  Phospholipase A2 in chamber angle of normal eyes and patients with primary open angle glaucoma and exfoliation glaucoma.

Authors:  Seppo Rönkkö; Petri Rekonen; Kai Kaarniranta; Tuomo Puustjarvi; Markku Teräsvirta; Hannu Uusitalo
Journal:  Mol Vis       Date:  2007-03-26       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.